Cargando…

Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells

Systemic lupus erythematosus (SLE) is an autoimmune disease with a broad range of clinical manifestations and a heterogeneous disease course. There is no cure for SLE, but current standard pharmacotherapies can improve disease prognosis in most patients. However, some patients are refractory to conv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Lihui, Labopin, Myriam, Badoglio, Manuela, Wang, Dandan, Sun, Lingyun, Farge-Bancel, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525791/ https://www.ncbi.nlm.nih.gov/pubmed/31191681 http://dx.doi.org/10.1155/2019/7061408

Ejemplares similares

A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2018)

Update on mesenchymal stem cell-based therapy in lupus and scleroderma
por: Cras, Audrey, et al.
Publicado: (2015)

Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2012)

Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties
por: Greco, Raffaella, et al.
Publicado: (2019)

Association of TNF-α with Impaired Migration Capacity of Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2014)

Serum IFN‐γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients
por: Wang, Dandan, et al.
Publicado: (2017)

Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus
por: Tani, Chiara, et al.
Publicado: (2017)

Umbilical Cord-Derived Mesenchymal Stem Cells Suppress Autophagy of T Cells in Patients with Systemic Lupus Erythematosus via Transfer of Mitochondria
por: Chen, Jinyun, et al.
Publicado: (2016)

Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
por: Wang, Dandan, et al.
Publicado: (2014)

Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients
por: Yuan, Xinran, et al.
Publicado: (2019)

Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs
por: Yao, Genhong, et al.
Publicado: (2022)

Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
por: Cao, Zhouli, et al.
Publicado: (2023)

Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2020)

Improved therapeutic consistency and efficacy of mesenchymal stem cells expanded with chemically defined medium for systemic lupus erythematosus
por: Xu, Jianyong, et al.
Publicado: (2020)

Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus
por: Zhu, Yantong, et al.
Publicado: (2018)

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus
por: Li, Aifen, et al.
Publicado: (2021)

A CD8 T Cell/Indoleamine 2,3-Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2014)

Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patients
por: Vanneaux, Valérie, et al.
Publicado: (2013)

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
por: Sharrack, Basil, et al.
Publicado: (2019)

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide
por: Audemard-Verger, Alexandra, et al.
Publicado: (2016)

Increase of Suicide and Accidental Death After Hematopoietic Stem Cell Transplantation: A Cohort Study on Behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
por: Tichelli, André, et al.
Publicado: (2013)

Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis
por: Zhang, Huayong, et al.
Publicado: (2017)

Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus
por: Tang, Yu, et al.
Publicado: (2012)

Stem Cell Therapy in the Treatment of Rheumatic Diseases and Application in the Treatment of Systemic Lupus Erythematosus
por: Leung, Patrick S. C., et al.
Publicado: (2016)

Autologous Haematopoietic Stem Cell Transplantation for Crohn’s Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation
por: Brierley, Charlotte K, et al.
Publicado: (2018)

Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
por: Cheng, Rui-Juan, et al.
Publicado: (2019)

Discoid lupus erythematosus of the nail treated with thalidomide
por: Harp, Taylor, et al.
Publicado: (2023)

Inhibition of Aberrant Circulating Tfh Cell Proportions by Corticosteroids in Patients with Systemic Lupus Erythematosus
por: Feng, Xuebing, et al.
Publicado: (2012)

Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT
por: Munker, Reinhold, et al.
Publicado: (2017)

Transmission of lupus anticoagulant by allogeneic stem cell transplantation
por: Massoud, Mira Romany, et al.
Publicado: (2014)

Immunogenicity of allogeneic mesenchymal stem cells
por: Schu, Sabine, et al.
Publicado: (2012)

Elevated Apoptosis and Impaired Proliferation Contribute to Downregulated Peripheral γ δ T Cells in Patients with Systemic Lupus Erythematosus
por: Lu, Zhimin, et al.
Publicado: (2013)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study
por: Liang, Jun, et al.
Publicado: (2018)

Terbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids
por: Kalińska-Bienias, Agnieszka, et al.
Publicado: (2013)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party
por: Henes, Joerg, et al.
Publicado: (2020)

Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus
por: Marmont du Haut Champ, Alberto M.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uo1ub6k4j18hc66qgmls1q0ns8